6533b7d7fe1ef96bd1268615
RESEARCH PRODUCT
Recent clinical evidence on metronomic dosing in controlled clinical trials: a systematic literature review.
Viktor WichmannAntti JekunenJatta SaarenheimoNatalja Eigelienesubject
medicine.medical_specialtymedicine.medical_treatmentAntineoplastic Agents030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineClinical Trials Phase II as TopicNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansRadiology Nuclear Medicine and imagingDosingIntensive care medicineRandomized Controlled Trials as TopicChemotherapybusiness.industryLow doseHematologyGeneral MedicineProgression-Free SurvivalCancer treatmentClinical trialSurvival RateSystematic reviewOncologyClinical Trials Phase III as TopicClinical evidence030220 oncology & carcinogenesisAdministration Metronomicbusinessdescription
Introduction: Metronomic dosing is used to give continuous chemotherapy at low doses. The low doses have minimal side effects and may enable cancer treatment to be remodeled toward the management o...
year | journal | country | edition | language |
---|---|---|---|---|
2020-04-11 | Acta oncologica (Stockholm, Sweden) |